bupropion

(redirected from Forfivo XL)
Also found in: Medical.

bu·pro·pi·on

 (byo͞o-prō′pē-ŏn′)
n.
A drug, C13H18ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

[bu(tyl) + propi(ophen)on(e), a ketone (propio(nic acid) + phen(yl) + -one).]

bupropion

(bjuːˈprəʊpɪɒn)
n
an antidepressant drug used to help people stop smoking
Translations

bupropion

n bupropión m
Mentioned in ?
References in periodicals archive ?
today announced that it has sold its royalty on future sales of Forfivo XL to SWK Holdings Corporation for $6 million (CAD$8 million).
Patent protection for Forfivo XL in the United States expires in 2027 with an authorized generic entering the market in January 2018.
11/782,838, entitled 'Controlled-release pharmaceutical tablets' which is related to the drug delivery technology used in Forfivo XL, IntelGenx' first FDA-approved product, currently commercialised in the United States.